- The $100 million Louvre theft could make France’s stolen Crown Jewels as famous as the Mona Lisa The Washington Post
- Louvre heist lift-maker seizes the moment with new ad campaign BBC
- ‘It’s Got to Be an Inside Job’: Jewelry Thieves Weigh In…
Blog
-
The $100 million Louvre theft could make France's stolen Crown Jewels as famous as the Mona Lisa – The Washington Post
-
With Dassai Sake Onboard, Successful H3 Rocket Launches Cargo Craft Toward ISS
Japan’s H3 No 7 rocket lifted off as scheduled at 9:00 AM on October 26 from the Tanegashima Space Center in Minamitane, Kagoshima Prefecture. About 14 minutes later, it successfully separated the new space station…
Continue Reading
-
Long-Term Follow-Up of Autologous Nasal Epithelial Stem Cell Transplantation for Congenital Olfactory Disorders in Children
BACKGROUND
Newswise — Congenital olfactory disorders (CODs) are rare but impactful conditions that impair the sense of smell from birth. These disorders can significantly affect a child’s appetite, nutrition,…
Continue Reading
-
Exercise and omega-3s could be the secret to healthier teeth
New research published in Scientific Reports has found that regular exercise paired with omega-3 supplementation can significantly enhance immune function and reduce the severity of chronic apical periodontitis, a type of inflammation that…
Continue Reading
-
Exercise and omega-3s could be the secret to healthier teeth
New research published in Scientific Reports has found that regular exercise paired with omega-3 supplementation can significantly enhance immune function and reduce the severity of chronic apical periodontitis, a type of inflammation that…
Continue Reading
-
TV tonight: a night of ghost-hunting with telly’s funniest siblings | Television & radio
Daisy May and Charlie Cooper’s NightWatch
9.30pm, BBC Two
Daisy May Cooper is late meeting her brother Charlie – she’s been busy stocking up in a crystal shop, before they set off on a tour of the UK’s spookiest places. They start with a…
Continue Reading
-
Croxley Green wine scam victim’s warning as fraudsters jailed
Nicola HaselerHertfordshire
BBC/Nicola HaselerTerry Fleming, 81, invested £40,000 over two years in what he thought was a profitable scheme A pensioner who ploughed £40,000 into a fraudulent wine investment scheme has warned others not to fall for similar scams after three men were jailed.
Terry Fleming, 81, from Croxley Green, Hertfordshire, said he invested the money over two years believing he would make a profit, but eventually had to sell the bottles at a considerable loss.
Three men who stole at least £6m from 41 victims in the scheme were given prison terms to at St Albans Crown Court on Friday.
Mr Fleming said the scam “sounded believable” but the men only “cared about how much money they were going to make”.
Benjamin Cazaly, 43, of Coach House, Orpington, south-east London, was jailed for six and a half years; Dominic D’Sa, 46, of Oxford Avenue, Wimbledon, south-west London, for four and a half years; and Gregory Assemakis, 40, of Plaistow Grove, Bromley, south-east London, for three and a half years.
They had been found guilty of fraudulent trading in August.
Cazaly founded Imperial Wines of London in 2008.
It claimed to be a family-run investment house with offices in Paris and Hong Kong.
In reality, it was a call centre in an office building in Groveland Court, London, which was raided by trading standards in November 2018.
An investigation by Hertfordshire Trading Standards found £37m passed through Imperial Wine & Spirits Merchants’ accounts during the 10 years it was trading.
Hertfordshire County CouncilThe company had the mantra “no means yes” written on the wall The mantra “no means yes” was written on the wall, and they used films such as The Wolf of Wall Street to learn manipulation tricks.
Cold callers used fake names and followed scripts – found when the office was raided – to persuade pensioners to hand over their money.
Victims were sent glossy brochures that used logos from the Daily Telegraph and the Financial Times without permission.
Hertfordshire County Council said the jury was played a recording where a confused woman was asked for payment card details despite not knowing what a card was or who she banked with.
It said the long-running scam saw pensioners convinced to spend their life savings on wine investments which had vastly inflated prices.
Investors were told the company did not make money unless the wine was sold at a profit.
Mr Fleming said: “It sounded believable.
“It didn’t seem like you were paying a small price and getting a huge return, it would be an average purchase price and a reasonable profit selling price.”
But staff from Imperial Wines of London kept contacting him.
“They offered me better and better deals,” he said.
“Instead of just a slight profit, these were really good wines that were going to make a lot of money. I said ‘no, no, no’ and they kept coming back trying to sell me more and more wine.”
What Mr Fleming didn’t realise was that the bottles he was paying £2,000 for were only worth £400. In the end he had to sell them at a loss.
“They sold some of it for me at a loss but some of the wine just disappeared,” he said.
“I just gave up in the end. All they cared about was how much money they were going to make. “
Hertfordshire County CouncilVictims were overcharged in the wine investment scheme, sometimes by 400%, National Trading Standards said Trish Burls, from National Trading Standards, said: “Victims in this case lost thousands of pounds through a co-ordinated scam of lies, deceit and manipulation.
“The criminals exploited people’s passion and enthusiasm, preying on them to invest while stripping many of their life savings and causing significant emotional distress.”
Ajanta Hilton, executive member for community safety at Hertfordshire County Council, added: “The stories of those targeted with this investment scam are devastating.
“I’d like to thank them for their bravery in telling their stories so that these callous criminals could be brought to justice.”
Mr Fleming said he is speaking out to prevent other people from falling for similar scams.
“However smooth and nice they seem, they’re not,” he said.
“The nicer they seem, the worse they are.
“A lot of people I know didn’t cope, and it must have been terrible for them because their lives have been ruined.
Continue Reading
-
The musician with millions of Spotify listeners
Olivia OsbyLiam McCay is possibly best known as Sign Crushes Motorist, although he has released music under a variety of names Liam McCay was driving down Sunset Boulevard in Los Angeles with a friend from Ireland when it set in just how different…
Continue Reading
-
Assessing Valuation After Launch of 5-Base Sequencing and Constellation Platform Advances
Illumina (ILMN) is capturing attention following the debut of its proprietary 5-base sequencing solution and impressive results from GeneDx’s pilot of the constellation platform. Both developments were showcased at the American Society for Human Genetics meeting.
See our latest analysis for Illumina.
Illumina’s shares have seen a notable rebound in recent weeks, logging a 9% gain over the last month as investors responded to a flurry of new product launches and encouraging partnerships. However, the stock is still down 24% on a year-to-date share price return basis, and its one-year total shareholder return stands at -29%, reflecting the longer road ahead for a sustained turnaround.
If Illumina’s fresh innovation streak has you watching the sector, it could be the perfect moment to browse other breakthroughs. See the full list of healthcare movers in See the full list for free.
But with Illumina’s fundamentals still recovering and shares trading below analyst price targets, investors are left to consider: is there real upside from here, or is future growth already priced into the stock?
Illumina’s narrative-based fair value estimate lands at $111.95, which is about $12 above the last close of $100.11. This gap spotlights perceived upside in the current share price versus analyst consensus.
Ongoing innovation, multiomics expansion, and operational efficiency are enhancing gross margins and creating new growth opportunities. Strategic expansion into multiomics, notably the planned acquisition of SomaLogic and integration of proteomics capabilities, creates incremental growth opportunities by increasing the breadth of Illumina’s data and platform offerings, contributing to future revenue and operating margin expansion.
Read the complete narrative.
Curious which bold, forward-looking financial shifts power this valuation? The answer lies in a mix of aggressive margin bets, platform scale-up strategies, and the kind of future earnings moves you might not expect. The most debated projections are all embedded here. Click through to discover what really drives this narrative.
Result: Fair Value of $111.95 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, persistent funding constraints and mounting regulatory hurdles in China still pose meaningful risks that could alter Illumina’s long-term trajectory.
Find out about the key risks to this Illumina narrative.
If you see things differently or want to run your own numbers, it’s quick and easy to craft a unique Illumina outlook in just minutes with Do it your way.
Continue Reading
-
Breaking Down Valuation After Strong Year-to-Date Share Price Gains
Uranium Energy (UEC) shares climbed 3% at the open, catching attention after a strong performance this year. With uranium prices in focus across the market, investors are watching to see if this momentum can continue.
See our latest analysis for Uranium Energy.
Uranium Energy’s share price has charged ahead this year, notching a year-to-date gain of 79.3%, and its 3-year total shareholder return sits at an impressive 223.7%. Recent volatility has been part of a broader surge in uranium equities, as shifting sentiment and renewed interest in the sector have pushed momentum higher instead of fading.
If the strength in uranium has you curious, it might be the perfect moment to expand your search and discover fast growing stocks with high insider ownership
The question now is whether Uranium Energy’s rally still leaves the shares undervalued, or if the current price already reflects all of the company’s future growth potential. Is there genuine upside left for buyers, or is the market a step ahead?
At a price-to-book ratio of 6.7x, Uranium Energy shares are trading at a premium to both industry peers and the broader sector. The last close price of $13.66 positions the stock in expensive territory on this metric, prompting a closer look at whether such a valuation holds up given where the company stands today.
The price-to-book ratio measures the market value of a company’s equity relative to its net assets. For resource-focused companies like Uranium Energy, where asset values play a crucial role, this multiple provides an essential snapshot for investors assessing whether the stock’s market value makes sense given its asset base.
Uranium Energy’s price-to-book of 6.7x is above the average for its peer group (5.8x) and far exceeds the broader US oil and gas industry average of 1.4x. This reflects a hefty premium. If the market were to move toward a lower, more typical level, it would represent a significant re-rating lower for the stock.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-Book of 6.7x (OVERVALUED)
However, if uranium prices retreat or investor enthusiasm subsides, Uranium Energy’s premium valuation could quickly come under pressure and alter the narrative ahead.
Find out about the key risks to this Uranium Energy narrative.
Switching lenses from asset multiples to our DCF model, Uranium Energy appears to be trading almost exactly at its calculated fair value. While the price-to-book ratio signals overvaluation, the discounted future cash flows suggest UEC could be fairly priced. Will the market follow the fundamentals, or do investors still expect more upside?
Continue Reading
